These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 35458417)
21. Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance. Louie A; Heine HS; VanScoy B; Eichas A; Files K; Fikes S; Brown DL; Liu W; Kinzig-Schippers M; Sörgel F; Drusano GL Antimicrob Agents Chemother; 2011 Feb; 55(2):822-30. PubMed ID: 21115791 [TBL] [Abstract][Full Text] [Related]
22. A Bacteriophage Cocktail Targeting Kilgore PB; Sha J; Hendrix EK; Neil BH; Lawrence WS; Peel JE; Hittle L; Woolston J; Sulakvelidze A; Schwartz JA; Chopra AK bioRxiv; 2024 Jan; ():. PubMed ID: 38293171 [No Abstract] [Full Text] [Related]
23. Reporter-Phage-Based Detection and Antibiotic Susceptibility Testing of Moses S; Aftalion M; Mamroud E; Rotem S; Steinberger-Levy I Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34208306 [TBL] [Abstract][Full Text] [Related]
25. [The lytic activity of Yersinia pestis phage P 3d serovar]. Novosel'tsev NN; Marchenkov VI; Kravchenko AN; Valentsev VE; Tinker LA Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):15-8. PubMed ID: 2099066 [TBL] [Abstract][Full Text] [Related]
26. [Yersinia pestis and plague - an update]. Stock I Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450 [TBL] [Abstract][Full Text] [Related]
27. A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague. Sha J; Rosenzweig JA; Kirtley ML; van Lier CJ; Fitts EC; Kozlova EV; Erova TE; Tiner BL; Chopra AK Microb Pathog; 2013 Feb; 55():39-50. PubMed ID: 23063826 [TBL] [Abstract][Full Text] [Related]
28. Rapid detection and simultaneous antibiotic susceptibility analysis of Yersinia pestis directly from clinical specimens by use of reporter phage. Vandamm JP; Rajanna C; Sharp NJ; Molineux IJ; Schofield DA J Clin Microbiol; 2014 Aug; 52(8):2998-3003. PubMed ID: 24920765 [TBL] [Abstract][Full Text] [Related]
29. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis. Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541 [TBL] [Abstract][Full Text] [Related]
30. Combinatorial Viral Vector-Based and Live Attenuated Vaccines without an Adjuvant to Generate Broader Immune Responses to Effectively Combat Pneumonic Plague. Kilgore PB; Sha J; Hendrix EK; Motin VL; Chopra AK mBio; 2021 Dec; 12(6):e0322321. PubMed ID: 34872353 [TBL] [Abstract][Full Text] [Related]
31. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination. Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734 [TBL] [Abstract][Full Text] [Related]
32. Complete Protection Against Zhang W; Song X; Zhai L; Guo J; Zheng X; Zhang L; Lv M; Hu L; Zhou D; Xiong X; Yang W Front Immunol; 2022; 13():793382. PubMed ID: 35154110 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic bioluminescent phage for detection of Yersinia pestis. Schofield DA; Molineux IJ; Westwater C J Clin Microbiol; 2009 Dec; 47(12):3887-94. PubMed ID: 19828743 [TBL] [Abstract][Full Text] [Related]
34. Standardized Method for Aerosol Challenge of Rodents with Yersinia pestis for Modeling Primary Pneumonic Plague. Anderson PE; Olson RM; Willix JL; Anderson DM Methods Mol Biol; 2019; 2010():29-39. PubMed ID: 31177429 [TBL] [Abstract][Full Text] [Related]
35. Tn-Seq Analysis Identifies Genes Important for Yersinia pestis Adherence during Primary Pneumonic Plague. Eichelberger KR; Sepúlveda VE; Ford J; Selitsky SR; Mieczkowski PA; Parker JS; Goldman WE mSphere; 2020 Aug; 5(4):. PubMed ID: 32759339 [TBL] [Abstract][Full Text] [Related]
36. [Effect of antibacterial therapy on the epidemic threat of experimental pneumonic plague in monkeys]. Romanov VE; Vasil'ev NT; Shabalin BA; Mironin AV Antibiot Khimioter; 2001; 46(4):16-8. PubMed ID: 11550501 [TBL] [Abstract][Full Text] [Related]
37. New Bacteriophages with Podoviridal Morphotypes Active against Suladze T; Jaiani E; Darsavelidze M; Elizbarashvili M; Gorge O; Kusradze I; Kokashvili T; Lashkhi N; Tsertsvadze G; Janelidze N; Chubinidze S; Grdzelidze M; Tsanava S; Valade E; Tediashvili M Viruses; 2023 Jun; 15(7):. PubMed ID: 37515171 [TBL] [Abstract][Full Text] [Related]
38. [Isolation and biological characteristics on Yersinia pestis phage YP060]. Li CX; Wang P; Shen XN; Zhang HP; Ding YB; Chen WJ; He YT; He QG; Huang Y; Li ZJ; Li W Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):868-71. PubMed ID: 27346118 [TBL] [Abstract][Full Text] [Related]
39. Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague. Tiner BL; Sha J; Kirtley ML; Erova TE; Popov VL; Baze WB; van Lier CJ; Ponnusamy D; Andersson JA; Motin VL; Chauhan S; Chopra AK Infect Immun; 2015 Apr; 83(4):1318-38. PubMed ID: 25605764 [TBL] [Abstract][Full Text] [Related]
40. Circumventing Y. pestis Virulence by Early Recruitment of Neutrophils to the Lungs during Pneumonic Plague. Vagima Y; Zauberman A; Levy Y; Gur D; Tidhar A; Aftalion M; Shafferman A; Mamroud E PLoS Pathog; 2015 May; 11(5):e1004893. PubMed ID: 25974210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]